Online citations, reference lists, and bibliographies.
← Back to Search

Therapeutic Nanosystems For Oral Administration Of Insulin.

F. A. do Carmo, P. Sathler, P. Zancan, C. R. Rodrigues, H. Castro, V. P. de Sousa, M. Sola-Penna, L. Cabral
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The treatment of Diabetes Mellitus (DM), a chronic disease, is primarily based upon administration of insulin forms to patients. Conventional subcutaneous administration is associated with a large number of complications, therefore, several new strategies have been developed. Amongst these strategies, oral insulin administration is much less invasive and, therefore, well tolerated. In recent years, various nanoformulations were developed for the oral administration of insulin, allowing more effective stabilization of the active pharmaceutical ingredient and modified for better absorption along the gastrointestinal tract. The development of different oral insulin nanoformulations in academic research as well as in patents, including the development of nanoparticles, liposomes, nanoemulsions and the use of cyclodextrins deserves special attention. The future of oral insulin nanoformulations is dependent on strategies utilizing simple technologies that stabilize the raw material, including inclusion within cyclodextrins or inclusion in low weight molecular mass polymers/ oligomers. All of the theories developed here provide a solid foundation upon which to develop new methods for the production of pharmaceutical peptide formulations. In addition, the effective search for existing nanometric formulations of insulin could provide economically viable therapeutic options that can consequently be produced on an industrial scale.
This paper references
10.1152/ajpgi.00107.2011
A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems.
J. W. Card (2011)
10.1016/j.ijpharm.2013.06.051
Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Xiuhua Zhao (2013)
10.1016/j.ejpb.2010.07.002
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
10.1016/j.carbpol.2012.03.095
Novel thermo- and pH-responsive hydroxypropyl cellulose- and poly (L-glutamic acid)-based microgels for oral insulin controlled release.
Yunyan Bai (2012)
10.1016/J.IJBIOMAC.2013.09.004
Radiation synthesis of multifunctional polymeric hydrogels for oral delivery of insulin.
M. A. Taleb (2013)
10.2217/DMT.10.5
Improving access to insulin: what can be done?
D. Beran (2011)
10.2147/IJN.S19917
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation
M. Niu (2011)
10.1016/j.ejpb.2009.06.004
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
10.1016/S0378-5173(01)00945-0
The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
K. Ståhl (2002)
10.1016/j.colsurfb.2013.06.019
Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery.
X. Y. Xiong (2013)
10.1016/j.amjmed.2013.06.011
Intensifying insulin therapy: what options are available to patients with type 2 diabetes?
L. Meneghini (2013)
10.1016/J.JCONREL.2007.03.022
Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.
J. Champion (2007)
10.1155/2014/943162
A Comprehensive Review on Metabolic Syndrome
J. Kaur (2014)
10.2337/diab.32.5.424
Physical Stability of Insulin Formulations
W. Lougheed (1983)
10.1016/j.ejps.2012.01.002
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
X. Zhang (2012)
10.1023/A:1015835017916
Chemical Stability of Insulin. 1. Hydrolytic Degradation During Storage of Pharmaceutical Preparations
J. Brange (2004)
10.3310/HTA11330
The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.
C. Black (2007)
10.1016/j.colsurfb.2011.11.040
Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing.
S. Jose (2012)
10.1016/j.ijbiomac.2013.03.064
Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
D. Tahtat (2013)
Advances in insulin therapy.
S. Kalra (2013)
10.1208/s12249-010-9561-2
Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents
Anumita Chaudhury (2010)
10.1016/j.nano.2014.02.014
Intestinal absorption of insulin nanoparticles: contribution of M cells.
M. A. Lopes (2014)
10.1016/j.biomaterials.2011.08.087
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
M. Chen (2011)
10.15403/JGLD-1282
Metabolic syndrome, insulin resistance, circadian disruption, antioxidants and pancreatic carcinoma: an overview.
A. Giudice (2014)
10.1016/j.ijpharm.2012.06.054
Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
Yajie Zhang (2012)
10.1016/j.jconrel.2009.12.018
Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice.
Y. Dekel (2010)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1211/jpp.59.7.0003
Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method
Y. You (2007)
10.1016/j.ijpharm.2013.01.017
Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents.
Angela Viehof (2013)
10.1111/j.1463-1326.2009.01150.x
Oral insulin – a review of current status
H. Iyer (2010)
10.1016/J.PROGPOLYMSCI.2012.04.004
Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
Piyasi Mukhopadhyay (2012)
10.1016/j.jconrel.2013.05.006
Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
Er-Yuan Chuang (2013)
10.1016/j.jconrel.2012.11.005
Polymeric hydrogels for oral insulin delivery.
K. Chaturvedi (2013)
APPLICATIONS OF NANOTECHNOLOGY IN DIABETES
A. K. Arya (2008)
10.1042/BST0351171
Insulin action on the liver in vivo.
A. Cherrington (2007)
10.2337/dcS13-2002
Insulin Therapy and Cancer
P. Home (2013)
10.1016/j.jconrel.2010.08.007
Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
S. Sajeesh (2010)
10.1016/j.ijpharm.2013.11.028
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.
M. Niu (2014)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
10.1016/j.ijpharm.2011.12.055
HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Z. M. Wu (2012)
10.1016/j.biomaterials.2010.01.045
Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin.
Lichen Yin (2010)
10.2337/dcS13-2007
Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs
Ofri Mosenzon (2013)
10.1016/j.ijbiomac.2013.08.034
Synthesis and evaluation of a novel β-cyclodextrin derivative for oral insulin delivery and absorption.
Liefeng Zhang (2013)
10.1016/j.addr.2011.10.006
Oral colon delivery of insulin with the aid of functional adjuvants.
A. Maroni (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar